Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950103-25-010166·Qiming Venture Partners IV, L.P.
Schedule 13G ownership disclosure
ZAI LAB LTD
Ordinary shares, par value US $0.000006 per share · CUSIP: 98887Q104
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Qiming Corporate GP IV, Ltd.
Shares: 66,329,320.00 · Class: 5.97%
- Qiming Managing Directors Fund IV, L.P
Shares: 2,030,208.00 · Class: 0.18%
- Qiming GP IV, L.P
Shares: 64,299,112.00 · Class: 5.79%
- Qiming Venture Partners IV, L.P.
Shares: 64,299,112.00 · Class: 5.79%
- QM11 Limited
Shares: 66,329,320.00 · Class: 5.97%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-25-010166
- Form type
- SCHEDULE 13G/A
- Filer
- Qiming Venture Partners IV, L.P.
- CIK
- CIK 1603597
- Filed
- Aug 12, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership